Typ 2 diabetes
Artiklar
Evolving Basal Insulin Therapy: From First-Generation to Second-Generation Analogues in Diabetes Care
Deliver-T (RWE Study): New Findings on Toujeo® for T2D Management Following Dual GIP/GLP-1 RA Therapy
Recognizing the Urgency to proactively plan a switch: Managing Timely Insulin Transitions for Continuity of Care
Learn why timely insulin transitions are critical for patient safety and continuity of care. Act early to avoid gaps and risks.
Psychological Considerations During Insulin Product Changes
Understanding the psychological burden of switching insulin. Discover ways to cope and support patient well-being during treatment changes.
Diabetes och Ramadan
2026 infaller Ramadan mellan 17 februari och 19 mars. Vi har tagit fram material för att hjälpa dig att stötta din patient med diabetes som vill fasta under Ramadan.
Utbildning
Personalized approach in T2D is key for success
The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.
.svg)
SE-FILMEN-HÄR
